80 related articles for article (PubMed ID: 38566115)
1. NF-kappaB as a therapeutic target in chronic lymphocytic leukemia.
Lopez-Guerra M; Colomer D
Expert Opin Ther Targets; 2010 Mar; 14(3):275-88. PubMed ID: 20148715
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
3. Non-canonical transcriptional regulation of the poor prognostic factor UGT2B17 in chronic lymphocytic leukemic and normal B cells.
Rouleau M; Villeneuve L; Allain EP; McCabe-Leroux J; Tremblay S; Nguyen Van Long F; Uchil A; Joly-Beauparlant C; Droit A; Guillemette C
BMC Cancer; 2024 Apr; 24(1):410. PubMed ID: 38566115
[TBL] [Abstract][Full Text] [Related]
4. UGT2B17 modifies drug response in chronic lymphocytic leukaemia.
Allain EP; Rouleau M; Vanura K; Tremblay S; Vaillancourt J; Bat V; Caron P; Villeneuve L; Labriet A; Turcotte V; Le T; Shehata M; Schnabl S; Demirtas D; Hubmann R; Joly-Beauparlant C; Droit A; Jäger U; Staber PB; Lévesque E; Guillemette C
Br J Cancer; 2020 Jul; 123(2):240-251. PubMed ID: 32418995
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of uridine diphospho glucuronosyltransferase 2B17 in high-risk chronic lymphocytic leukemia.
Gruber M; Bellemare J; Hoermann G; Gleiss A; Porpaczy E; Bilban M; Le T; Zehetmayer S; Mannhalter C; Gaiger A; Shehata M; Fleiss K; Skrabs C; Lévesque É; Vanura K; Guillemette C; Jaeger U
Blood; 2013 Feb; 121(7):1175-83. PubMed ID: 23169782
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of Prostaglandin E
Allain EP; Rouleau M; Le T; Vanura K; Villeneuve L; Caron P; Turcotte V; Lévesque E; Guillemette C
Front Oncol; 2019; 9():606. PubMed ID: 31334126
[TBL] [Abstract][Full Text] [Related]
7. STAT3 and NF-κB cooperatively control in vitro spontaneous apoptosis and poor chemo-responsiveness in patients with chronic lymphocytic leukemia.
Liu FT; Jia L; Wang P; Wang H; Farren TW; Agrawal SG
Oncotarget; 2016 May; 7(22):32031-45. PubMed ID: 27074565
[TBL] [Abstract][Full Text] [Related]
8. Untargeted metabolomics identifies metabolic dysregulation of sphingolipids associated with aggressive chronic lymphocytic leukaemia and poor survival.
Nguyen Van Long F; Valcourt-Gendron D; Caron P; Rouleau M; Villeneuve L; Simonyan D; Le T; Sergerie R; Laverdière I; Vanura K; Guillemette C
Clin Transl Med; 2023 Dec; 13(12):e1442. PubMed ID: 38037464
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of the UDP-glucuronosyltransferase transcriptome in human tissues.
Zhou L; Montalvo AD; Collins JM; Wang D
Pharmacol Res Perspect; 2023 Dec; 11(6):e01154. PubMed ID: 37983911
[TBL] [Abstract][Full Text] [Related]
10. A Non-Canonical Role for the Glycosyltransferase Enzyme UGT2B17 as a Novel Constituent of the B Cell Receptor Signalosome.
Wagner A; Rouleau M; Villeneuve L; Le T; Peltier C; Allain ÉP; Beaudoin C; Tremblay S; Courtier F; Nguyen Van Long F; Laverdière I; Lévesque É; Banerji V; Vanura K; Guillemette C
Cells; 2023 May; 12(9):. PubMed ID: 37174695
[TBL] [Abstract][Full Text] [Related]
11. HERVs and Cancer-A Comprehensive Review of the Relationship of Human Endogenous Retroviruses and Human Cancers.
Stricker E; Peckham-Gregory EC; Scheurer ME
Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979914
[TBL] [Abstract][Full Text] [Related]
12. Pan-cancer analysis identifies tumor-specific antigens derived from transposable elements.
Shah NM; Jang HJ; Liang Y; Maeng JH; Tzeng SC; Wu A; Basri NL; Qu X; Fan C; Li A; Katz B; Li D; Xing X; Evans BS; Wang T
Nat Genet; 2023 Apr; 55(4):631-639. PubMed ID: 36973455
[TBL] [Abstract][Full Text] [Related]
13. Interferon gamma regulates a complex pro-survival signal network in chronic lymphocytic leukemia.
Chen Y; Shao X; Yang H; Ren L; Cui Y; Zhang W; Macip S; Meng X
Eur J Haematol; 2023 Apr; 110(4):435-443. PubMed ID: 36576398
[TBL] [Abstract][Full Text] [Related]
14. IFN-γ enhances CLL cell resistance to ABT-199 by regulating MCL-1 and BCL-2 expression via the JAK-STAT3 signaling pathway.
Shao X; Meng X; Yang H; Wang X; Qin L; Shen G; Xi X; Zhao H; Macip S; Chen Y
Leuk Lymphoma; 2023 Jan; 64(1):71-78. PubMed ID: 36222521
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
